Cost-utility analysis of treatment initiation with subcutaneous ketamine for TRD from the KADS Study
Вставка
- Опубліковано 29 жов 2024
- Day 3 - 16.25pm - Wednesday 27th March 2024 - Speaker: Colleen Loo (University of New South Wales, Sydney, Australia)